Basic Information
Basic information for SNHG17-219-101aa
Peptide Name SNHG17-219-101aa
Genome Position chr20:38431523-38431825[-]
Species Human
Peptide Sequence MRSVLWRSGALCPTRVGACRFPGRDVWEVERGEVRVSLCWPQFYPLWGHHEYIGFLLCLLGFSIFRDPLSLLCLGISDSKAGGLWHQTYLYLGPKRFTTTP
Peptide Length 101
Unique No (SNHG17-223-101aa)
Grand Average of Hydropathicity 0.0842
Relative Molecular Mass 13392.13
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000196756;SNHG17
Transcript ID/Name ENST00000654853;SNHG17-219
Transcript Length 2079
Coding Ability 0.4319
DNA Sequence Corresponding to Peptide ATGAGGTCTGTCCTCTGGAGATCTGGGGCTTTGTGTCCCACAAGGGTGGGTGCATGCAGGTTCCCTGGGCGTGATGTCTGGGAAGTAGAGAGAGGTGAGGTAAGAGTGTCTTTGTGCTGGCCCCAGTTTTACCCTCTTTGGGGCCATCATGAATACATTGGGTTCCTCTTGTGCCTGCTTGGGTTTAGCATCTTTAGGGATCCCTTATCATTGTTGTGTCTTGGAATATCTGACTCAAAAGCTGGAGGGCTTTGGCATCAAACCTACCTGTACCTTGGTCCCAAACGCTTTACCACTACTCCC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :